Siemens Healthineers, Mayo Clinic Expand Collaboration to Enhance Patient Care

The organizations aim to improve diagnosis and treatment for neurodegenerative disease, prostate cancer, and metastatic liver tumors.

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

Siemens Healthineers and Mayo Clinic have agreed to expand their strategic collaboration to enhance patient care, with a focus on improving the diagnosis and treatment of neurodegenerative disease, prostate cancer, and metastatic liver tumors. The collaboration will involve the development of AI-enabled MRI protocols, the application of digital twin technology to improve the surgical experience, and the clinical adoption of advanced imaging technologies.

Why it matters

This collaboration between a leading medical technology company and a renowned healthcare institution has the potential to significantly improve patient outcomes and experiences in the management of complex neurological and oncological conditions. By leveraging advanced imaging, artificial intelligence, and innovative treatment approaches, the organizations aim to deliver more precise, less invasive, and personalized care.

The details

The expanded collaboration between Siemens Healthineers and Mayo Clinic will focus on several key areas. For neurodegenerative disease, the organizations will work to advance AI-enabled MRI protocols for improved diagnostic accuracy and patient monitoring. They also plan to apply digital twin technology to re-imagine the surgical experience and improve operational efficiency. In the realm of prostate cancer, the collaboration will investigate the role of AI in minimizing biopsies and the integration of minimally invasive, advanced imaging into diagnostic and therapeutic procedures. For metastatic liver tumors, Siemens Healthineers and Mayo Clinic aim to deliver clinical translation for image-guided technologies, enabling precise detection and treatment.

  • The collaboration agreement was announced on February 13, 2026.

The players

Siemens Healthineers

A leading medical technology company that develops and manufactures diagnostic and therapeutic imaging equipment, laboratory diagnostics, and molecular medicine solutions.

Mayo Clinic

A nonprofit organization committed to clinical practice, education, and research, recognized as one of the world's leading healthcare providers.

John Kowal

President and head of the Americas at Siemens Healthineers.

Dr. Eric Williamson

Professor and chair of diagnostic radiology at Mayo Clinic.

Got photos? Submit your photos here. ›

What they’re saying

“Improving the diagnosis and treatment of neurodegenerative disease and cancer is core to our purpose as a company. Our collaboration with Mayo Clinic creates significant opportunities to help extend the quantity and quality of patients' lives.”

— John Kowal, President and head of the Americas at Siemens Healthineers (massdevice.com)

“Our goal is to make care more precise, less invasive, and more responsive to each patient's needs. By expanding our collaboration, we can bring advanced imaging, artificial intelligence, and innovative treatment approaches directly into everyday clinical care, potentially helping patients receive earlier diagnoses, more personalized treatment plans, and better outcomes.”

— Dr. Eric Williamson, Professor and chair of diagnostic radiology at Mayo Clinic (massdevice.com)

What’s next

The organizations plan to establish an innovation center for whole-body PET/CT and PET/MR imaging, with a focus on theranostics treatment for certain cancers and simultaneous anatomical and metabolic MR imaging.

The takeaway

This expanded collaboration between Siemens Healthineers and Mayo Clinic demonstrates the potential for leading medical technology companies and renowned healthcare institutions to work together to drive innovation and improve patient care in complex neurological and oncological conditions. By leveraging advanced imaging, artificial intelligence, and personalized treatment approaches, the organizations aim to deliver more precise, less invasive, and responsive care to patients.